dacarbazine has been researched along with Cancer of Nose in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benito, M; Mintzer, DM; Nagamine, M; Newman, J; Zheng, S | 1 |
Lee, N; Setton, J | 1 |
Dichgans, J; Küker, W; Weller, M; Wick, A; Wick, W | 1 |
Bessho, A; Mogami, H; Nakata, M; Okita, R; Teramoto, N; Yamashita, M | 1 |
Kharoubi, S | 1 |
Eich, HT; Eich, PD; Micke, O; Müller, R; Staar, S; Stützer, H | 1 |
6 other study(ies) available for dacarbazine and Cancer of Nose
Article | Year |
---|---|
Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell cancer center of Pennsylvania Hospital.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Dacarbazine; Esthesioneuroblastoma, Olfactory; Humans; Hydrocortisone; Immunohistochemistry; Ketoconazole; Magnetic Resonance Imaging; Male; Middle Aged; Nasal Cavity; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nose Neoplasms; Octreotide; Temozolomide | 2010 |
Melanoma metastatic to multiple visceral organs: further considerations.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Dose Fractionation, Radiation; Humans; Melanoma; Neoplasm Metastasis; Nose Neoplasms; Palliative Care; Prognosis | 2010 |
Intracranial metastatic esthesioneuroblastoma responsive to temozolomide.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Esthesioneuroblastoma, Olfactory; Female; Humans; Middle Aged; Nasal Cavity; Nose Neoplasms; Quality of Life; Temozolomide | 2004 |
Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Melanocytes; Melanoma; Middle Aged; Nasal Cavity; Nose Neoplasms; Picibanil; Tegafur; Tomography, X-Ray Computed; Uracil | 2005 |
[Malignant melanoma of nasal fossae: clinical and therapeutic considerations about three cases].
Topics: Aged; Antineoplastic Agents, Alkylating; Biopsy; Combined Modality Therapy; Dacarbazine; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nasal Mucosa; Nasal Septum; Neoplasm Metastasis; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Time Factors; Turbinates | 2005 |
Radiotherapy of esthesioneuroblastoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Dacarbazine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Female; Follow-Up Studies; Humans; Lomustine; Male; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Vincristine | 2001 |